Last reviewed · How we verify
amoxicillin clavulanate acid
amoxicillin clavulanate acid is a Small molecule drug developed by Oulu University Hospital. It is currently FDA-approved. Also known as: Clavurion mixture (Orion Oy).
At a glance
| Generic name | amoxicillin clavulanate acid |
|---|---|
| Also known as | Clavurion mixture (Orion Oy) |
| Sponsor | Oulu University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis) (PHASE2)
- Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics (PHASE4)
- Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients. (PHASE3)
- Amoxicillin/Clavulanic Acid Susceptibility in Acute Community-acquired Pneumonia Requiring Intensive Care Management
- Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children (PHASE2)
- Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis (PHASE4)
- Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP (PHASE4)
- Collaborative Urological Prosthetics Investigation Directive Research Group (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- amoxicillin clavulanate acid CI brief — competitive landscape report
- amoxicillin clavulanate acid updates RSS · CI watch RSS
- Oulu University Hospital portfolio CI
Frequently asked questions about amoxicillin clavulanate acid
What is amoxicillin clavulanate acid?
amoxicillin clavulanate acid is a Small molecule drug developed by Oulu University Hospital.
Who makes amoxicillin clavulanate acid?
amoxicillin clavulanate acid is developed and marketed by Oulu University Hospital (see full Oulu University Hospital pipeline at /company/oulu-university-hospital).
Is amoxicillin clavulanate acid also known as anything else?
amoxicillin clavulanate acid is also known as Clavurion mixture (Orion Oy).
What development phase is amoxicillin clavulanate acid in?
amoxicillin clavulanate acid is FDA-approved (marketed).
Related
- Manufacturer: Oulu University Hospital — full pipeline
- Also known as: Clavurion mixture (Orion Oy)
- Compare: amoxicillin clavulanate acid vs similar drugs
- Pricing: amoxicillin clavulanate acid cost, discount & access